Evaluation of Reader Training Processes
NCT02051790
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
241
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer's Disease
Interventions
DRUG:
florbetapir F 18
Sponsor
Avid Radiopharmaceuticals